Emilio Gastaldi

Papers

1

Total Citations

30

H-Index

1

About

Emilio Gastaldi is a leading figure in urologic oncology, with a focused research portfolio centered on optimizing treatment strategies for prostate cancer. His work critically compares the efficacy and outcomes of modern surgical and radiotherapeutic approaches, particularly robot-assisted radical prostatectomy (RARP) and brachytherapy (BT). His most cited study, a prospective randomized trial from 2017 (30 citations), directly addresses the management of low-risk prostate cancer, providing valuable head-to-head data on oncological control and functional preservation. This contribution is pivotal for clinicians navigating the complex decision-making landscape for early-stage disease, offering evidence to guide patient counseling. Beyond this landmark paper, Gastaldi’s broader research investigates minimally invasive surgical techniques and their impact on patient quality of life. By generating high-quality comparative evidence, his work helps refine clinical guidelines and underscores the importance of personalized treatment in urology. His findings continue to influence urologic practice, making him a respected voice in the ongoing effort to balance cancer control with functional outcomes for men with prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Robotic prostatectomy versus brachytherapy for the treatment of low risk prostate cancer.
30 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago